Skip to main content

Research Repository

Advanced Search

Pancreatic neuroendocrine tumours: a comparison of cytological classification systems.

Ackroyd, Lauren; Hanks, Matthew; Bancu, Andrei; Khan, Marium; Sajid, Saira; Lobo, Dileep N; Zaitoun, Abed M

Pancreatic neuroendocrine tumours: a comparison of cytological classification systems. Thumbnail


Authors

Lauren Ackroyd

Matthew Hanks

Andrei Bancu

Marium Khan

Saira Sajid

DILEEP LOBO dileep.lobo@nottingham.ac.uk
Professor of Gastrointestinal Surgery

Abed M Zaitoun



Abstract

Aims: Cytological classification systems provide a standardised interpretation framework for reporting cytological specimens. Three well-known classification systems can be applied when reporting pancreatic cytology. This study aimed to compare the accuracy of these classification systems (C1–C5 system, the Papanicolaou system and the WHO classification) for the assessment of pancreatic neuroendocrine lesions.

Methods: We analysed 73 pancreatic neuroendocrine tumour resections, 49 of which had corroborative cytology available, reported over a 12-year period, at a single UK tertiary referral centre. Each cytology case was classified using the aforementioned systems. The final tumour grade allocated at resection was used to assess and compare the accuracy of each cytological classification system.

Results: Cytological assessment accurately reported 77.6% of neuroendocrine lesions as category IVB (neoplastic - other) on Papanicolaou grading, 77.6% as C5 (malignant) lesions and 85.7% as VII (malignant) on WHO grading. 74.3% of resected tumours were grade 1, 17.1% grade 2 and 8.6% grade 3. Complete resection was achieved in 80.8% of cases.

Conclusions: The results demonstrated that the WHO classification appeared to provide reduced ambiguity when compared with both ‘C’ and Papanicolaou classification systems; with a lower proportion of cases being classified as suspicious of malignancy as opposed to malignant. The Papanicolaou system was able to supersede the other two systems through its ability to distinguish neuroendocrine tumours from more aggressive entities such as pancreatic adenocarcinoma, thus, offering flexibility in management while still retaining a similar level of accuracy to the WHO classification system in distinguishing benign from malignant lesions.

Citation

Ackroyd, L., Hanks, M., Bancu, A., Khan, M., Sajid, S., Lobo, D. N., & Zaitoun, A. M. (2024). Pancreatic neuroendocrine tumours: a comparison of cytological classification systems. Journal of Clinical Pathology, Article jcp-2024-209507. https://doi.org/10.1136/jcp-2024-209507

Journal Article Type Article
Acceptance Date Apr 3, 2024
Online Publication Date May 15, 2024
Publication Date May 15, 2024
Deposit Date Apr 4, 2024
Publicly Available Date May 15, 2024
Journal Journal of Clinical Pathology
Print ISSN 0021-9746
Electronic ISSN 1472-4146
Publisher BMJ Publishing Group
Peer Reviewed Peer Reviewed
Article Number jcp-2024-209507
DOI https://doi.org/10.1136/jcp-2024-209507
Keywords Neuroendocrine, Pancreatic Neoplasms, Classification
Public URL https://nottingham-repository.worktribe.com/output/33290939
Publisher URL https://jcp.bmj.com/content/early/2024/05/14/jcp-2024-209507

Files





You might also like



Downloadable Citations